Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors



Status:Completed
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:2/2/2018
Start Date:July 2012
End Date:January 28, 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Estimating the Adherence Rate of a Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

This study aims to establish the feasibility of using a monthly bubble package to improve
compliance rates among women prescribed adjuvant endocrine therapy.

This study uses Bubble packaging to provide a cost effective way to improve compliance and
help direct further interventions to ensure adherence in women on anti-estrogen therapy for
breast cancer.

Inclusion Criteria:

- 18 years of age or older

- Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry

- Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine
therapy

Exclusion Criteria:

- Patients with metastatic disease (stage IV)

- Patients less than 18 years of age

- Prisoners

- Patients are unable to fill prescriptions at the BCC pharmacy due to insurance
limitations or personal preference
We found this trial at
1
site
James Graham Brown Cancer Center, University of Louisville
Louisville, Kentucky 40202
Principal Investigator: Elizabeth C Riley, MD
Phone: 502-562-3429
?
mi
from
Louisville, KY
Click here to add this to my saved trials